R. Kessler, P. Berglund, O. Demler, J. R. Koretz, D. Merikangas et al., The Epidemiology of Major Depressive Disorder, JAMA, vol.289, issue.23, pp.3095-105, 2003.
DOI : 10.1001/jama.289.23.3095

P. Sobocki, B. Jonsson, J. Angst, and C. Rehnberg, Cost of depression in Europe, J Ment Health Policy Econ, vol.9, issue.2, pp.87-98, 2006.

J. Alonso, M. Angermeyer, S. Bernert, R. Bruffaerts, T. Brugha et al., Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand Suppl, issue.420, pp.21-28, 2004.

D. Milea, P. Verpillat, F. Guelfucci, M. Toumi, and M. Lamure, Prescription patterns of antidepressants: findings from a US claims database, Current Medical Research and Opinion, vol.26, issue.6, 2010.
DOI : 10.1185/03007991003772096

D. Milea, F. Guelfucci, N. Bent-ennakhil, M. Toumi, and J. Auray, Antidepressant monotherapy treatment for depression: a claims database analysis of treatment changes and duration of treatment, Clin Ther, 2010.

D. Milea, M. Toumi, N. Bent-ennakhil, and J. Donohue, Evolution of antidepressants consumption in the USA and in nine different European countries during the last decade, 2010.

M. Thase, Long-term treatments of recurrent depressive disorders, J Clin Psychiatry, vol.53, pp.32-44, 1992.

L. Judd, M. Paulus, and P. Zeller, The Role of Residual Subthreshold Depressive Symptoms in Early Episode Relapse in Unipolar Major Depressive Disorder, Archives of General Psychiatry, vol.56, issue.8, pp.764-769, 1999.
DOI : 10.1001/archpsyc.56.8.763

S. M. Stahl, Essential Pharmacology of Depression and Bipolar Disorder, 2008.

J. Storosum, B. Van-zwieten, H. Vermeulen, T. Wohlfarth, . Van-den et al., Relapse and recurrence prevention in major depression: a critical review of placebo-controlled efficacy studies with special emphasis on methodological issues, European Psychiatry, vol.16, issue.6, pp.327-362, 2001.
DOI : 10.1016/S0924-9338(01)00587-9

G. Belsher and C. Costello, Relapse after recovery from unipolar depression: A critical review., Psychological Bulletin, vol.104, issue.1, pp.84-96, 1988.
DOI : 10.1037/0033-2909.104.1.84

C. Melfi, A. Chawla, T. Croghan, M. Hanna, S. Kennedy et al., The Effects of Adherence to Antidepressant Treatment Guidelines on Relapse and Recurrence of Depression, Archives of General Psychiatry, vol.55, issue.12, pp.1128-1160, 1998.
DOI : 10.1001/archpsyc.55.12.1128

S. Burcusa and W. Iacono, Risk for recurrence in depression, Clinical Psychology Review, vol.27, issue.8, pp.959-85, 2007.
DOI : 10.1016/j.cpr.2007.02.005

J. Kocsis, New strategies for treating chronic depression, J Clin Psychiatry, vol.61, issue.11, pp.42-47, 2000.

M. Fava, Management of nonresponse and intolerance: switching strategies, J Clin Psychiatry, vol.61, issue.2, pp.10-12, 2000.

M. Fava, New approaches to the treatment of refractory depression, J Clin Psychiatry, vol.61, issue.1, pp.26-32, 2000.

M. Berlim and G. Turecki, Definition, Assessment, and Staging of Treatment???Resistant Refractory Major Depression: A Review of Current Concepts and Methods, The Canadian Journal of Psychiatry, vol.58, issue.8, pp.46-54, 2007.
DOI : 10.1177/070674370705200108

C. Nemeroff, Prevalence and management of treatment-resistant depression, J Clin Psychiatry, vol.68, issue.8, pp.17-25, 2007.

R. Kessler and T. Üstün, The WHO World Mental Health Surveys, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00585164

J. Alonso and J. Lepine, Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD), J Clin Psychiatry, vol.68, issue.2, pp.3-9, 2007.

R. Kessler and K. Merikangas, The National Comorbidity Survey Replication (NCS-R): background and aims, International Journal of Methods in Psychiatric Research, vol.285, issue.2, pp.60-68, 2004.
DOI : 10.1002/mpr.166

D. Regier, J. Myers, M. Kramer, L. Robins, D. Blazer et al., The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics, Arch Gen Psychiatry, 1984.
DOI : 10.1001/archpsyc.1984.01790210016003

K. Demyttenaere, R. Bruffaerts, J. Posada-villa, I. Gasquet, V. Kovess et al., Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys, JAMA, vol.291, issue.2721, pp.2581-90, 2004.

J. Alonso, M. Ferrer, B. Romera, G. Vilagut, M. Angermeyer et al., The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methods, International Journal of Methods in Psychiatric Research, vol.159, issue.2, pp.55-67, 2002.
DOI : 10.1002/mpr.123

J. Alonso, M. Angermeyer, S. Bernert, R. Bruffaerts, T. Brugha et al., Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand Suppl, issue.420, pp.8-20, 2004.

I. Gasquet, L. Negre-pages, A. Fourrier, G. Nachbaur, A. El-hasnaoui et al., Usage des psychotropes et troubles psychiatriques en France : r??sultats de l?????tude ??pid??miologique ESEMeD/MHEDEA 2000/ (ESEMeD) en population g??n??rale, L'Enc??phale, vol.31, issue.2, pp.195-206, 2005.
DOI : 10.1016/S0013-7006(05)82386-3

J. Lepine, M. Gastpar, J. Mendlewicz, and A. Tylee, Depression in the community, International Clinical Psychopharmacology, vol.12, issue.1
DOI : 10.1097/00004850-199701000-00003

J. Ayuso-mateos, J. Vazquez-barquero, C. Dowrick, V. Lehtinen, O. Dalgard et al., Depressive disorders in Europe: prevalence figures from the ODIN study, The British Journal of Psychiatry, vol.179, issue.4, pp.308-324, 2001.
DOI : 10.1192/bjp.179.4.308

R. Kessler, O. Demler, R. Frank, M. Olfson, H. Pincus et al., Prevalence and treatment of mental disorders, N Engl J Med, issue.33, 1990.

H. Baumeister and M. Harter, Prevalence of mental disorders based on general population surveys, Social Psychiatry and Psychiatric Epidemiology, vol.162, issue.suppl. 420, pp.537-583, 2007.
DOI : 10.1007/s00127-007-0204-1

R. Kessler, P. Berglund, W. Chiu, O. Demler, M. Glantz et al., The National Comorbidity Survey Replication (NCS-R): Cornerstone in Improving Mental Health and Mental Heath care in the United States, The WHO Wolrd Mental Health Surveys, pp.165-209, 2008.

R. Lieb, B. Isensee, M. Hofler, and H. Wittchen, Parental depression and depression in offspring: evidence for familial characteristics and subtypes?, Journal of Psychiatric Research, vol.36, issue.4, pp.237-283, 2002.
DOI : 10.1016/S0022-3956(02)00015-8

A. Nierenberg, M. Trivedi, M. Fava, M. Biggs, K. Shores-wilson et al., Family history of mood disorder and characteristics of major depressive disorder: A STAR???D (sequenced treatment alternatives to relieve depression) study, Journal of Psychiatric Research, vol.41, issue.3-4, pp.3-4214, 2007.
DOI : 10.1016/j.jpsychires.2006.02.005

P. Sullivan, M. Neale, and K. Kendler, Genetic Epidemiology of Major Depression: Review and Meta-Analysis, American Journal of Psychiatry, vol.157, issue.10, pp.1552-62, 2000.
DOI : 10.1176/appi.ajp.157.10.1552

J. Murphy, J. Burke, J. Monson, R. Horton, N. Laird et al., Mortality associated with depression, Social Psychiatry and Psychiatric Epidemiology, vol.262, issue.4, pp.594-601, 2008.
DOI : 10.1007/s00127-008-0323-3

F. Amaddeo, G. Bisoffi, P. Bonizzato, R. Micciolo, and M. Tansella, Mortality among patients with psychiatric illness. A ten-year case register study in an area with a community-based system of care, The British Journal of Psychiatry, vol.166, issue.6, pp.783-791, 1995.
DOI : 10.1192/bjp.166.6.783

J. Gallo, H. Bogner, K. Morales, E. Post, H. Ten et al., Depression, Cardiovascular Disease, Diabetes, and Two-Year Mortality Among Older, Primary-Care Patients, The American Journal of Geriatric Psychiatry, vol.13, issue.9, pp.748-55, 2005.
DOI : 10.1097/00019442-200509000-00002

J. Greden, Recurrent depression. Its overwhelming burden. Treatment of Recurrent Depression, pp.1-18, 2001.

J. Ballenger, J. Davidson, Y. Lecrubier, D. Nutt, D. Goldberg et al., Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety, J Clin Psychiatry, vol.60, issue.43 7, pp.54-61, 1999.

S. Roose, D. Devanand, and K. Suthers, Depression, Mayo Clinic Proceedings, vol.76, issue.3, pp.20-26, 1999.
DOI : 10.4065/76.3.347

C. Dickens, L. Mcgowan, C. Percival, B. Tomenson, L. Cotter et al., New Onset Depression Following Myocardial Infarction Predicts Cardiac Mortality, Psychosomatic Medicine, vol.70, issue.4, pp.450-455, 2008.
DOI : 10.1097/PSY.0b013e31816a74de

E. Martens and J. De, Developing depression after a myocardial infarction increases risk of cardiac mortality but pre-existing depression does not. Evid Based Ment Health, Feb, vol.12, issue.1, p.8, 2009.

K. Parakh, B. Thombs, J. Fauerbach, D. Bush, and R. Ziegelstein, Effect of Depression on Late (8 years) Mortality After Myocardial Infarction, The American Journal of Cardiology, vol.101, issue.5, pp.602-608, 2008.
DOI : 10.1016/j.amjcard.2007.10.021

M. Keller, Depression: a long-term illness, Br J Psychiatry, issue.48, 1994.

R. Anderson, K. Freedland, R. Clouse, and P. Lustman, The Prevalence of Comorbid Depression in Adults With Diabetes: A meta-analysis, Diabetes Care, vol.24, issue.6, 2001.
DOI : 10.2337/diacare.24.6.1069

G. De, R. Anderson, K. Freedland, R. Clouse, and P. Lustman, Association of depression and diabetes complications: a meta-analysis, Psychosom Med, issue.50, 2001.

R. Hirschfeld, S. Montgomery, M. Keller, S. Kasper, A. Schatzberg et al., Social Functioning in Depression, The Journal of Clinical Psychiatry, vol.61, issue.4, 2000.
DOI : 10.4088/JCP.v61n0405

H. Andrea, U. Bultmann, L. Van-amelsvoort, and Y. Kant, The incidence of anxiety and depression among employees-the role of psychosocial work characteristics, Depression and Anxiety, vol.11, issue.11, pp.1040-1048, 2009.
DOI : 10.1002/da.20516

L. Judd, P. Schettler, D. Solomon, J. Maser, W. Coryell et al., Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders, Journal of Affective Disorders, vol.108, issue.1-2, pp.49-58, 2008.
DOI : 10.1016/j.jad.2007.06.014

R. Kessler, K. Merikangas, and P. Wang, The Prevalence and Correlates of Workplace Depression in the National Comorbidity Survey Replication, Journal of Occupational and Environmental Medicine, vol.50, issue.4, pp.381-90, 2008.
DOI : 10.1097/JOM.0b013e31816ba9b8

G. Simon, D. Revicki, J. Heiligenstein, L. Grothaus, M. Vonkorff et al., Recovery from depression, work productivity, and health care costs among primary care patients, General Hospital Psychiatry, vol.22, issue.3, pp.153-62, 2000.
DOI : 10.1016/S0163-8343(00)00072-4

G. Simon, E. Ludman, J. Unutzer, B. Operskalski, and M. Bauer, Severity of mood symptoms and work productivity in people treated for bipolar disorder, Bipolar Disorders, vol.57, issue.6, pp.718-743, 2008.
DOI : 10.1111/j.1399-5618.2008.00581.x

R. Kessler, H. Akiskal, M. Ames, H. Birnbaum, P. Greenberg et al., Prevalence and Effects of Mood Disorders on Work Performance in a Nationally Representative Sample of U.S. Workers, American Journal of Psychiatry, vol.163, issue.9, pp.1561-1569, 2006.
DOI : 10.1176/ajp.2006.163.9.1561

C. Murray and A. Lopez, Alternative projections of mortality and disability by cause 1990???2020: Global Burden of Disease Study, The Lancet, vol.349, issue.9064, pp.1498-504, 1997.
DOI : 10.1016/S0140-6736(96)07492-2

P. Greenberg, H. Birnbaum, R. Kessler, M. Morgan, and P. Stang, Impact of Illness and Its Treatment on Workplace Costs: Regulatory and Measurement Issues, Journal of Occupational and Environmental Medicine, vol.43, issue.1, pp.56-63, 2001.
DOI : 10.1097/00043764-200101000-00011

P. Greenberg, R. Kessler, H. Birnbaum, S. Leong, S. Lowe et al., The Economic Burden of Depression in the United States, The Journal of Clinical Psychiatry, vol.64, issue.12, pp.1465-75, 2000.
DOI : 10.4088/JCP.v64n1211

L. Pape and A. Lt, Prévalence et prise en charge médicale de la dépression en 1996-1997. CREDES, 1999.

J. Alonso, M. Angermeyer, S. Bernert, R. Bruffaerts, T. Brugha et al., Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand Suppl, issue.420, pp.47-54, 2004.

P. Wang, M. Lane, M. Olfson, H. Pincus, K. Wells et al., Twelve-Month Use of Mental Health Services in the United States, Archives of General Psychiatry, vol.62, issue.6, pp.629-669, 2005.
DOI : 10.1001/archpsyc.62.6.629

V. Kovess-masfety, J. Alonso, T. Brugha, M. Angermeyer, J. Haro et al., Differences in Lifetime Use of Services for Mental Health Problems in Six European Countries, Psychiatric Services, vol.58, issue.2, pp.213-233, 2007.
DOI : 10.1176/ps.2007.58.2.213

C. Montano and M. Montano, A New Paradigm for Treating Depression in the Primary Care Setting, 2002.

J. Alonso, M. Angermeyer, S. Bernert, R. Bruffaerts, T. Brugha et al., Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand Suppl, issue.420, pp.55-64, 2004.

A. Fernandez, J. Haro, M. Martinez-alonso, K. Demyttenaere, T. Brugha et al., Treatment adequacy for anxiety and depressive disorders in six European countries, The British Journal of Psychiatry, vol.190, issue.2, pp.172-175, 2007.
DOI : 10.1192/bjp.bp.106.023507

E. Driessen and S. Hollon, Cognitive Behavioral Therapy for Mood Disorders: Efficacy, Moderators and Mediators, Psychiatric Clinics of North America, vol.33, issue.3, 2010.
DOI : 10.1016/j.psc.2010.04.005

F. Bymaster, R. Mcnamara, and P. Tran, New approaches to developing antidepressants by enhancing monoaminergic neurotransmission, Expert Opinion on Investigational Drugs, vol.283, issue.975, pp.531-574, 2003.
DOI : 10.1046/j.1460-9568.2000.00982.x

C. Barbui, A. Cipriani, T. Furukawa, G. Salanti, J. Higgins et al., Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal? Evid Based Ment Health, pp.101-105, 2009.

A. Cipriani, J. Geddes, T. Furukawa, and C. Barbui, Metareview on Short-Term Effectiveness and Safety of Antidepressants for Depression: An Evidence-Based Approach to Inform Clinical Practice, The Canadian Journal of Psychiatry, vol.65, issue.12, pp.553-62, 2007.
DOI : 10.1016/S0009-9236(02)17634-X

A. Cipriani, T. Furukawa, G. Salanti, J. Geddes, J. Higgins et al., Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, The Lancet, vol.373, issue.9665, pp.746-58, 2009.
DOI : 10.1016/S0140-6736(09)60046-5

R. Rahimi, S. Nikfar, and M. Abdollahi, Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: A meta-analysis, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.33, issue.1, pp.118-145, 2009.
DOI : 10.1016/j.pnpbp.2008.10.018

R. Shelton and . St, ) in Major Depression, The Journal of Clinical Psychiatry, vol.70, issue.suppl 5, pp.23-30, 2009.
DOI : 10.4088/JCP.8157su1c.05

M. Bauer and W. Task, World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care, The World Journal of Biological Psychiatry, vol.34, issue.3, pp.67-104, 2007.
DOI : 10.1097/00004583-199611000-00018

H. Agency, R. Lam, S. Kennedy, S. Grigoriadis, R. Mcintyre et al., Treatment of major depression Clin Pract Guide 12, 5. 1993. rockville, Md, US Department of health and Human services Ref Type: Unpublished Work (81) Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy, J Affect Disord, vol.117, issue.80 1, pp.26-43, 2009.

J. Davidson, Major Depressive Disorder Treatment Guidelines in America and Europe, The Journal of Clinical Psychiatry, vol.71, issue.suppl E1, 2010.
DOI : 10.4088/JCP.9058se1c.04gry

J. Geddes, S. Carney, C. Davies, T. Furukawa, D. Kupfer et al., Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review, The Lancet, vol.361, issue.9358, pp.653-61, 2003.
DOI : 10.1016/S0140-6736(03)12599-8

T. Melartin, H. Rytsala, U. Leskela, P. Lestela-mielonen, T. Sokero et al., Continuity Is the Main Challenge in Treating Major Depressive Disorder in Psychiatric Care, The Journal of Clinical Psychiatry, vol.66, issue.02, pp.220-227, 2005.
DOI : 10.4088/JCP.v66n0210

S. Kornstein, A. Bose, D. Li, K. Saikali, and C. Gandhi, Escitalopram Maintenance Treatment for Prevention of Recurrent Depression, The Journal of Clinical Psychiatry, vol.67, issue.11, pp.1767-75, 2006.
DOI : 10.4088/JCP.v67n1115

F. Rouillon, B. Warner, N. Pezous, and J. Bisserbe, Milnacipran efficacy in the prevention of recurrent depression: a 12-month placebo-controlled study. Milnacipran recurrence prevention study group, Int Clin Psychopharmacol, 2000.

J. Lepine, V. Caillard, J. Bisserbe, S. Troy, J. Hotton et al., A Randomized, Placebo-Controlled Trial of Sertraline for Prophylactic Treatment of Highly Recurrent Major Depressive Disorder, American Journal of Psychiatry, vol.161, issue.5, pp.836-878, 2004.
DOI : 10.1176/appi.ajp.161.5.836

D. Kupfer, E. Frank, J. Perel, C. Cornes, A. Mallinger et al., Five-Year Outcome for Maintenance Therapies in Recurrent Depression, Archives of General Psychiatry, vol.49, issue.10, pp.769-73, 1992.
DOI : 10.1001/archpsyc.1992.01820100013002

M. Fava, A. Rush, M. Trivedi, A. Nierenberg, M. Thase et al., Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR???D) study, Psychiatric Clinics of North America, vol.26, issue.2, pp.457-94, 2003.
DOI : 10.1016/S0193-953X(02)00107-7

R. Howland, Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Part 1: study design, J Psychosoc Nurs Ment Health Serv, 2008.

R. Howland, Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Part 2: Study outcomes, J Psychosoc Nurs Ment Health Serv, issue.94, 2008.

M. Trivedi, A. Rush, S. Wisniewski, A. Nierenberg, D. Warden et al., Evaluation of outcomes with citalopram for depression using measurementbased care in STAR*D: implications for clinical practice, Am J Psychiatry, 2006.

A. Rush, M. Trivedi, S. Wisniewski, J. Stewart, A. Nierenberg et al., Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression, New England Journal of Medicine, vol.354, issue.12, pp.1231-1273, 2006.
DOI : 10.1056/NEJMoa052963

M. Fava, A. Rush, S. Wisniewski, A. Nierenberg, J. Alpert et al., A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report, American Journal of Psychiatry, vol.163, issue.7, pp.1161-72, 2006.
DOI : 10.1176/ajp.2006.163.7.1161

P. Mcgrath, J. Stewart, M. Fava, M. Trivedi, S. Wisniewski et al., Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report, American Journal of Psychiatry, vol.163, issue.9, pp.1531-1572, 2006.
DOI : 10.1176/ajp.2006.163.9.1531

A. Nierenberg, M. Fava, M. Trivedi, S. Wisniewski, M. Thase et al., A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report, Am J Psychiatry, issue.99, 2006.

A. Rush, M. Trivedi, S. Wisniewski, A. Nierenberg, J. Stewart et al., Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report, Am J Psychiatry, issue.100, 2006.

J. Rosholm, M. Andersen, and L. Gram, Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study, European Journal of Clinical Pharmacology, vol.56, issue.12, pp.923-932, 2001.
DOI : 10.1007/s002280000234

S. Peretti, R. Judge, and I. Hindmarch, Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors, Acta Psychiatrica Scandinavica, vol.56, issue.6, pp.17-25, 2000.
DOI : 10.1002/(SICI)1099-1557(199707)6:4<235::AID-PDS293>3.3.CO;2-V

M. Olfson, S. Marcus, H. Pincus, J. Zito, J. Thompson et al., Antidepressant Prescribing Practices of Outpatient Psychiatrists, Archives of General Psychiatry, vol.55, issue.4, pp.310-316, 1998.
DOI : 10.1001/archpsyc.55.4.310

F. Langer, M. Olfson, S. Marcus, B. Druss, L. Elinson et al., National trends in the outpatient treatment of depression, JAMA, vol.287, issue.2, pp.203-212, 2002.

R. Mojtabai and M. Olfson, National Patterns in Antidepressant Treatment by Psychiatrists and General Medical Providers, The Journal of Clinical Psychiatry, vol.69, issue.7, pp.1064-74, 2008.
DOI : 10.4088/JCP.v69n0704

P. Pariente, J. Lepine, and J. Lellouch, Self-reported psychotropic drug use and associated factors in a French community sample, Psychological Medicine, vol.18, issue.01, 1992.
DOI : 10.1016/0165-0327(90)90009-W

M. Bouhassira, M. Allicar, C. Blachier, A. Nouveau, and F. Rouillon, Which patients receive antidepressants? A `real world' telephone study, Journal of Affective Disorders, vol.49, issue.1, 1998.
DOI : 10.1016/S0165-0327(97)00193-6

F. Rouillon, C. Blachier, J. Dreyfus, M. Bouhassira, and M. Allicar, [Pharmacoepidemiologic study of the use of antidepressant drugs in the general population], Encephale, vol.22, issue.110 1, pp.39-48, 1996.

J. Lecadet, P. Vidal, and B. Paris, Médicaments psychotropes : consommation et pratiques de prescription en France métropolitaine. I. Données nationales, Rev Med Assu Mal, vol.34, pp.75-83, 2000.

W. Meijer, E. Heerdink, H. Leufkens, R. Herings, A. Egberts et al., Incidence and determinants of long-term use of antidepressants, European Journal of Clinical Pharmacology, vol.60, issue.1, pp.57-61, 2004.
DOI : 10.1007/s00228-004-0726-3

H. Gardarsdottir, E. Heerdink, and A. Egberts, Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands, Pharmacoepidemiology and Drug Safety, vol.90, issue.5, pp.338-381, 2006.
DOI : 10.1002/pds.1223

K. Demyttenaere, A. Bonnewyn, R. Bruffaerts, G. De, I. Gasquet et al., Clinical factors influencing the prescription of antidepressants and benzodiazepines:, Journal of Affective Disorders, vol.110, issue.1-2, pp.84-93, 2008.
DOI : 10.1016/j.jad.2008.01.011

A. Claxton, Z. Li, and J. Mckendrick, Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression, The British Journal of Psychiatry, vol.177, issue.2, 2000.
DOI : 10.1192/bjp.177.2.163

R. Hirschfeld, Clinical importance of long-term antidepressant treatment, The British Journal of Psychiatry, vol.179, issue.42, pp.4-8, 2001.
DOI : 10.1192/bjp.179.42.s4

P. Fender and A. Weill, [Epidemiology, public health and medical rates databases]. Rev Epidemiol Sante Publique, pp.113-120, 2004.

K. Furu, B. Wettermark, M. Andersen, J. Martikainen, A. Almarsdottir et al., The Nordic Countries as a Cohort for Pharmacoepidemiological Research, Basic & Clinical Pharmacology & Toxicology, vol.63, issue.2, pp.86-94, 2010.
DOI : 10.1111/j.1742-7843.2009.00494.x

D. Regier, R. Hirschfeld, F. Goodwin, J. Burke, J. Lazar et al., The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis, Am J Psychiatry, vol.145, issue.11, pp.1351-1358, 1988.

R. Goldman and M. Montagne, Marketing ???mind mechanics???: Decoding antidepressant drug advertisements, Social Science & Medicine, vol.22, issue.10, pp.1047-58, 1986.
DOI : 10.1016/0277-9536(86)90205-4

A. Nikelly, Drug advertisements and the medicalization of unipolar depression in women. Health Care Women Int, pp.229-271, 1995.

B. Lowe, R. Spitzer, K. Grafe, K. Kroenke, A. Quenter et al., Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians? diagnoses, Journal of Affective Disorders, vol.78, issue.2, pp.131-171, 2004.
DOI : 10.1016/S0165-0327(02)00237-9

M. Zimmerman, T. Sheeran, and D. Young, The Diagnostic Inventory for Depression: A self-report scale to diagnose DSM-IV major depressive disorder, Journal of Clinical Psychology, vol.44, issue.1, pp.87-110, 2004.
DOI : 10.1002/jclp.10207

M. Hemels, G. Koren, and T. Einarson, Increased Use of Antidepressants in Canada: 1981???2000, Annals of Pharmacotherapy, vol.52, issue.9, pp.1375-1384, 2002.
DOI : 10.1345/aph.1A331

C. Beck, S. Patten, J. Williams, J. Wang, S. Currie et al., Antidepressant utilization in Canada, Social Psychiatry and Psychiatric Epidemiology, vol.41, issue.Suppl 1, 2005.
DOI : 10.1007/s00127-005-0968-0

T. Brugha, P. Bebbington, N. Singleton, D. Melzer, R. Jenkins et al., Trends in service use and treatment for mental disorders in adults throughout Great Britain, The British Journal of Psychiatry, vol.185, issue.5, pp.378-84, 2004.
DOI : 10.1192/bjp.185.5.378

R. Mojtabai, Increase in Antidepressant Medication in the US Adult Population between 1990 and 2003, Psychotherapy and Psychosomatics, vol.77, issue.2, pp.83-92, 1990.
DOI : 10.1159/000112885

R. Paulose-ram, M. Safran, B. Jonas, Q. Gu, and D. Orwig, Trends in psychotropic medication use among U.S. adults, Pharmacoepidemiology and Drug Safety, vol.51, issue.5, 2007.
DOI : 10.1002/pds.1367

A. Ubeda, E. Cardo, N. Selles, R. Broseta, J. Trillo et al., Antidepressant utilization in primary care in a Spanish region, Social Psychiatry and Psychiatric Epidemiology, vol.20, issue.Suppl 1, pp.181-189, 2000.
DOI : 10.1007/s00127-006-0149-9

C. Barbui, A. Campomori, D. Avanzo, B. Negri, E. Garattini et al., Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates, Social Psychiatry and Psychiatric Epidemiology, vol.34, issue.3, 1999.
DOI : 10.1007/s001270050127

A. Smith, I. Sketris, C. Cooke, D. Gardner, S. Kisely et al., A comparison of antidepressant use in Nova Scotia, Canada and Australia, Pharmacoepidemiology and Drug Safety, vol.35, issue.9, pp.697-706, 2008.
DOI : 10.1002/pds.1541

A. Ciuna, M. Andretta, L. Corbari, D. Levi, M. Mirandola et al., Are we going to increase the use of antidepressants up to that of benzodiazepines?, European Journal of Clinical Pharmacology, vol.72, issue.9, pp.629-663, 2004.
DOI : 10.1007/s00228-004-0810-8

R. Stafford, E. Macdonald, and S. Finkelstein, National Patterns of Medication Treatment for Depression, 1987 to 2001, The Primary Care Companion to The Journal of Clinical Psychiatry, vol.03, issue.06, pp.232-237, 1987.
DOI : 10.4088/PCC.v03n0611

M. Ufer, S. Meyer, O. Junge, G. Selke, H. Volz et al., Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis, Pharmacoepidemiology and Drug Safety, vol.20, issue.10, 2007.
DOI : 10.1002/pds.1405

C. Pietraru, C. Barbui, L. Poggio, and G. Tognoni, Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database, European Journal of Clinical Pharmacology, vol.57, issue.8, 2001.
DOI : 10.1007/s002280100361

E. Poluzzi, D. Motola, C. Silvani, P. De, A. Vaccheri et al., Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement, European Journal of Clinical Pharmacology, vol.59, issue.11, pp.825-856, 2004.
DOI : 10.1007/s00228-003-0692-1

G. Trifiro, C. Barbui, E. Spina, S. Moretti, M. Tari et al., Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years, Pharmacoepidemiol Drug Saf, issue.140, 2003.

M. Moore, H. Yuen, N. Dunn, M. Mullee, J. Maskell et al., Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database, BMJ, vol.339, issue.oct15 2, p.3999, 2009.
DOI : 10.1136/bmj.b3999

D. Amar and E. Balsan, les ventes d'antidépresseurs entre http://www sante gouv fr/drees/serieetudes, 1980.

J. Dubernard, Rapport sur le bon usage des médicaments psychotropes, 2006.

L. Kihlstrom, Managed care and medication compliance: Implications for chronic depression, The Journal of Behavioral Health Services & Research, vol.30, issue.Suppl. 1, pp.367-76, 1998.
DOI : 10.1007/BF02287508

R. Freeman, Newer agents for the treatment of painful diabetic peripheral neuropathy, Current Diabetes Reports, vol.96, issue.suppl 3, pp.409-425, 2005.
DOI : 10.1007/s11892-005-0047-7

M. Ohayon, M. Caulet, R. Priest, and C. Guilleminault, Psychotropic Medication Consumption Patterns in the UK General Population, Journal of Clinical Epidemiology, vol.51, issue.3, 1998.
DOI : 10.1016/S0895-4356(97)00238-2

T. Saarto and P. Wiffen, Antidepressants for neuropathic pain, Cochrane Database Syst Rev, issue.3, p.5454, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00557402

D. Sheehan, M. Keene, M. Eaddy, S. Krulewicz, J. Kraus et al., Differences in Medication Adherence??and Healthcare Resource??Utilization Patterns, CNS Drugs, vol.177, issue.4, pp.963-73, 2008.
DOI : 10.2165/00023210-200822110-00005

A. Libby, D. Brent, E. Morrato, H. Orton, R. Allen et al., Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs, American Journal of Psychiatry, vol.164, issue.6, pp.884-91, 2007.
DOI : 10.1176/ajp.2007.164.6.884

S. Kisely, M. Linden, C. Bellantuono, G. Simon, and J. Jones, Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study, Psychological Medicine, vol.30, issue.5, pp.1217-1242, 2000.
DOI : 10.1017/S0033291799002743

H. Gardarsdottir, E. Heerdink, D. Van, and A. Egberts, Indications for antidepressant drug prescribing in general practice in the Netherlands, Journal of Affective Disorders, vol.98, issue.1-2, 2007.
DOI : 10.1016/j.jad.2006.07.003

S. Henriksson, G. Boethius, J. Hakansson, and G. Isacsson, Indications for and outcome of antidepressant medication in a general population: a prescription database and medical record study, in Jamtland county, Sweden, 1995, Jamtland county, Sweden, pp.427-458, 1995.
DOI : 10.1034/j.1600-0447.2002.02432.x

S. Sihvo, E. Isometsa, O. Kiviruusu, J. Hamalainen, J. Suvisaari et al., Antidepressant utilisation patterns and determinants of short-term and nonpsychiatric use in the Finnish general adult population, J Affect Disord, 2008.

E. Esposito, J. Wang, C. Adair, J. Williams, K. Dobson et al., Frequency and adequacy of depression treatment in a Canadian population sample, Can J Psychiatry, vol.52, issue.12, pp.780-789, 2007.

A. Garcia-cebrian, M. Bauer, A. Montejo, N. Dantchev, K. Demyttenaere et al., Factors influencing depression endpoints research (FINDER): Study design and population characteristics, European Psychiatry, vol.23, issue.1, pp.57-65, 2008.
DOI : 10.1016/j.eurpsy.2007.10.002

R. Mojtabai, Americans' Attitudes Toward Mental Health Treatment Seeking: 1990???2003, Psychiatric Services, vol.58, issue.5, pp.642-51, 2007.
DOI : 10.1176/ps.2007.58.5.642

I. Anderson, Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability, Journal of Affective Disorders, vol.58, issue.1, 2000.
DOI : 10.1016/S0165-0327(99)00092-0

S. Byrne and A. Rothschild, Psychiatrists' responses to failure of maintenance therapy with antidepressants, Psychiatr Serv, vol.48, issue.6, pp.835-842, 1997.

D. Mischoulon, A. Nierenberg, L. Kizilbash, J. Rosenbaum, and M. Fava, Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians, The Canadian Journal of Psychiatry, vol.43, issue.5, pp.476-81, 2000.
DOI : 10.1177/070674370004500509

S. Shergill and C. Katona, Pharmacological choices after one antidepressant fails: a survey of UK psychiatrists, Journal of Affective Disorders, vol.43, issue.1, pp.19-25, 1997.
DOI : 10.1016/S0165-0327(96)00100-0

M. Bauer and S. Dopfmer, Lithium Augmentation in Treatment-Resistant Depression: Meta-Analysis of Placebo-Controlled Studies, Journal of Clinical Psychopharmacology, vol.19, issue.5, 1999.
DOI : 10.1097/00004714-199910000-00006

I. Jackson, Does Thyroid Hormone Have a Role as Adjunctive Therapy in Depression?1, Thyroid, vol.6, issue.1, pp.63-70, 1996.
DOI : 10.1089/thy.1996.6.63

R. Shelton, G. Tollefson, M. Tohen, S. Stahl, K. Gannon et al., A Novel Augmentation Strategy for Treating Resistant Major Depression, American Journal of Psychiatry, vol.158, issue.1, pp.131-135, 2001.
DOI : 10.1176/appi.ajp.158.1.131

M. Trivedi, A. Rush, B. Gaynes, J. Stewart, S. Wisniewski et al., Maximizing the Adequacy of Medication Treatment in Controlled Trials and Clinical Practice: STAR*D Measurement-Based Care, Neuropsychopharmacology, vol.58, issue.12, 2007.
DOI : 10.1038/sj.npp.1301390

D. Warden, A. Rush, M. Trivedi, M. Fava, and S. Wisniewski, The STAR*D project results: A comprehensive review of findings, Current Psychiatry Reports, vol.5, issue.Suppl16, 2007.
DOI : 10.1007/s11920-007-0061-3

M. Keller, R. Hirschfeld, K. Demyttenaere, and D. Baldwin, Optimizing outcomes in depression: focus on antidepressant compliance, International Clinical Psychopharmacology, vol.17, issue.6, 2002.
DOI : 10.1097/00004850-200211000-00001

M. Eaddy, B. Druss, M. Sarnes, T. Regan, and L. Frankum, Relationship of Total Health Care Charges to Selective Serotonin Reuptake Inhibitor Utilization Patterns Including the Length of Antidepressant Therapy Results From a Managed Care Administrative Claims Database, Journal of Managed Care Pharmacy, vol.11, issue.2, pp.145-50, 2005.
DOI : 10.18553/jmcp.2005.11.2.145

S. Marcus, M. Hassan, and M. Olfson, Antidepressant Switching Among Adherent Patients Treated for Depression, Psychiatric Services, vol.60, issue.5, pp.617-640, 2009.
DOI : 10.1176/ps.2009.60.5.617

R. Sheffield, L. Sasso, A. Young, C. Way, and K. , Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization, Administration and Policy in Mental Health, vol.30, issue.2, pp.121-160, 2002.
DOI : 10.1023/A:1022533118031

N. Sood, M. Treglia, R. Obenchain, B. Dulisse, C. Melfi et al., Determinants of antidepressant treatment outcome, Am J Manag Care, issue.174, 2000.

C. Mullins, F. Shaya, F. Meng, J. Wang, and D. Harrison, Persistence, Switching, and Discontinuation Rates Among Patients Receiving Sertraline, Paroxetine, and Citalopram, Pharmacotherapy, vol.58, issue.5, pp.660-667, 2005.
DOI : 10.4088/JCP.v60n0902

N. Keks, G. Burrows, D. Copolov, R. Newton, N. Paoletti et al., Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?, Med J Aust Feb, vol.5186, issue.3, pp.142-146, 2007.

M. Trivedi, M. Fava, S. Wisniewski, M. Thase, F. Quitkin et al., Medication Augmentation after the Failure of SSRIs for Depression, New England Journal of Medicine, vol.354, issue.12, pp.1243-52, 2006.
DOI : 10.1056/NEJMoa052964

M. Olfson and S. Marcus, National Patterns in Antidepressant Medication Treatment, Archives of General Psychiatry, vol.66, issue.8, pp.848-56, 2009.
DOI : 10.1001/archgenpsychiatry.2009.81

D. Hodgkin, C. Horgan, D. Garnick, M. Len, and J. Volpe-vartanian, Management of access to branded psychotropic medications in private health plans, Clinical Therapeutics, vol.29, issue.2, pp.371-80, 2007.
DOI : 10.1016/j.clinthera.2007.02.011

G. Simon, J. Heiligenstein, D. Revicki, M. Vonkorff, W. Katon et al., Long-term Outcomes of Initial Antidepressant Drug Choice in a "Real World" Randomized Trial, Archives of Family Medicine, vol.8, issue.4, pp.319-344, 1999.
DOI : 10.1001/archfami.8.4.319

R. Khandker, D. Kruzikas, and T. Mclaughlin, Pharmacy and Medical Costs Associated With Switching Between Venlafaxine and SSRI Antidepressant Therapy for the Treatment of Major Depressive Disorder, Journal of Managed Care Pharmacy, vol.14, issue.5, 2008.
DOI : 10.18553/jmcp.2008.14.5.426

E. Sullivan, R. Griffiths, R. Frank, M. Strauss, R. Herbert et al., Oneyear costs of second-line therapies for depression, J Clin Psychiatry, issue.182, 2000.

J. Schultz and V. Joish, Costs associated with changes in antidepressant treatment in a managed care population with major depressive disorder, Psychiatr Serv, 2009.

G. Alexopoulos, I. Katz, C. Reynolds, . Iii, D. Carpenter et al., Pharmacotherapy of Depression in Older Patients: A Summary of the Expert Consensus Guidelines, Journal of Psychiatric Practice, vol.7, issue.6, pp.361-76, 2001.
DOI : 10.1097/00131746-200111000-00003

B. Mulsant, G. Alexopoulos, C. Reynolds, I. Katz, I. Abrams et al., Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm, International Journal of Geriatric Psychiatry, vol.283, issue.6, pp.585-92, 2001.
DOI : 10.1002/gps.465

D. Dobrez, C. Melfi, T. Croghan, T. Kniesner, and R. Obenchain, Antidepressant treatment for depression: total charges and therapy duration, The Journal of Mental Health Policy and Economics, vol.10, issue.4, pp.187-97, 2000.
DOI : 10.1002/mhp.95

H. Gardarsdottir, E. Van-geffen, J. Stolker, T. Egberts, and E. Heerdink, Does the Length of the First Antidepressant Treatment Episode Influence Risk and Time to a Second Episode?, Journal of Clinical Psychopharmacology, vol.29, issue.1, pp.69-72, 2009.
DOI : 10.1097/JCP.0b013e31819302b1

R. Tierney, C. Melfi, W. Signa, T. Croghan, G. Isacsson et al., Antidepressant use and use patterns in naturalistic settings. Drug benefit trends Ref Type: Generic (189) Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database, J Affect Disord, vol.53, issue.1, pp.15-22, 1999.

M. Eaddy, T. Bramley, and T. Regan, Time to antidepressant discontinuation: a comparison of controlled-release paroxetine and immediate-release selective serotonin-reuptake inhibitors, Manag Care Interface, vol.16, issue.12, pp.22-29, 2003.

M. Olfson, S. Marcus, M. Tedeschi, and G. Wan, Continuity of Antidepressant Treatment for Adults With Depression in the United States, American Journal of Psychiatry, vol.163, issue.1, 2006.
DOI : 10.1176/appi.ajp.163.1.101

M. Vanelli and M. Coca-perraillon, Role of patient experience in antidepressant adherence: A retrospective data analysis, Clinical Therapeutics, vol.30, issue.9, pp.1737-1782, 2008.
DOI : 10.1016/j.clinthera.2008.08.014

M. Serna, I. Cruz, J. Real, E. Gasco, and L. Galvan, Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database???, European Psychiatry, vol.25, issue.4, pp.206-219, 2010.
DOI : 10.1016/j.eurpsy.2009.07.012

H. Gardarsdottir, A. Egberts, D. Van, M. Sturkenboom, and E. Heerdink, An algorithm to identify antidepressant users with a diagnosis of depression from prescription data, Pharmacoepidemiology and Drug Safety, vol.143, issue.1, pp.7-15, 2009.
DOI : 10.1002/pds.1677

R. Robinson, S. Long, S. Chang, S. Able, O. Baser et al., Higher Costs and Therapeutic Factors Associated With Adherence to NCQA HEDIS Antidepressant Medication Management Measures: Analysis of Administrative Claims, Journal of Managed Care Pharmacy, vol.12, issue.1, pp.43-54, 2006.
DOI : 10.18553/jmcp.2006.12.1.43

J. Angst, Major depression in 1998: are we providing optimal therapy?, J Clin Psychiatry, vol.60, issue.6, pp.5-9, 1999.

D. Hansen, W. Vach, J. Rosholm, J. Sondergaard, L. Gram et al., Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics, Family Practice, vol.21, issue.6, pp.623-632, 2004.
DOI : 10.1093/fampra/cmh608

P. Landsman, W. Yu, X. Liu, S. Teutsch, and M. Berger, Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization, Am J Manag Care, vol.11, issue.10, pp.621-629, 2005.

H. Gardarsdottir, T. Egberts, J. Stolker, and E. Heerdink, Duration of Antidepressant Drug Treatment and Its Influence on Risk of Relapse/Recurrence: Immortal and Neglected Time Bias, American Journal of Epidemiology, vol.170, issue.3, pp.280-285, 2009.
DOI : 10.1093/aje/kwp142

I. Wilson, K. Duszynski, and A. Mant, A 5-year follow-up of general practice patients experiencing depression, Family Practice, vol.20, issue.6, pp.685-694, 2003.
DOI : 10.1093/fampra/cmg611

T. Croghan, C. Melfi, W. Crown, and A. Chawla, Cost-effectiveness of antidepressant medications, The Journal of Mental Health Policy and Economics, vol.1, issue.3, pp.109-126, 1998.
DOI : 10.1002/(SICI)1099-176X(1998100)1:3<109::AID-MHP15>3.0.CO;2-2

W. Crown, S. Finkelstein, E. Berndt, D. Ling, A. Poret et al., The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs, The Journal of Clinical Psychiatry, vol.63, issue.11, pp.963-71, 2002.
DOI : 10.4088/JCP.v63n1102

J. Aikens, K. Kroenke, R. Swindle, and G. Eckert, Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care, General Hospital Psychiatry, vol.27, issue.4, pp.229-265, 2005.
DOI : 10.1016/j.genhosppsych.2005.04.001

E. Van-geffen, H. Van, M. Bouvy, A. Egberts, and E. Heerdink, Characteristics and Reasons Associated with Nonacceptance of Selective Serotonin-Reuptake Inhibitor Treatment, Annals of Pharmacotherapy, vol.22, issue.2, pp.218-243, 2008.
DOI : 10.1345/aph.1K516

A. Sicras-mainar, M. Blanca-tamayo, L. Gutierrez-nicuesa, J. Salvatella-pasant, and R. Navarro-artieda, Clinical validity of a population database definition of remission in patients with major depression, BMC Public Health, vol.57, issue.Supl 1, p.64, 2010.
DOI : 10.1192/bjp.179.4.317